Deal Watch: MacroGenics Offloads Margenza To TerSera As Focus Shifts To Pipeline
Lilly unit explores external innovation with insitro and Qinotto, plus deals involving Novartis/3BP, Eterna/Factor, Molecure/Ocean, Bayer/MOMA, Virios/Wex and more.
Lilly unit explores external innovation with insitro and Qinotto, plus deals involving Novartis/3BP, Eterna/Factor, Molecure/Ocean, Bayer/MOMA, Virios/Wex and more.